These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32142617)

  • 1. Current advances in the algae-made biopharmaceuticals field.
    Rosales-Mendoza S; Solís-Andrade KI; Márquez-Escobar VA; González-Ortega O; Bañuelos-Hernandez B
    Expert Opin Biol Ther; 2020 Jul; 20(7):751-766. PubMed ID: 32142617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green biologics: The algal chloroplast as a platform for making biopharmaceuticals.
    Taunt HN; Stoffels L; Purton S
    Bioengineered; 2018 Jan; 9(1):48-54. PubMed ID: 28892417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlamydomonas reinhardtii as a viable platform for the production of recombinant proteins: current status and perspectives.
    Rosales-Mendoza S; Paz-Maldonado LM; Soria-Guerra RE
    Plant Cell Rep; 2012 Mar; 31(3):479-94. PubMed ID: 22080228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae.
    Barolo L; Abbriano RM; Commault AS; George J; Kahlke T; Fabris M; Padula MP; Lopez A; Ralph PJ; Pernice M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32151094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stramenopile microalgae as "green biofactories" for recombinant protein production.
    de Grahl I; Reumann S
    World J Microbiol Biotechnol; 2021 Aug; 37(9):163. PubMed ID: 34453200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering microalgae through chloroplast transformation to produce high-value industrial products.
    Siddiqui A; Wei Z; Boehm M; Ahmad N
    Biotechnol Appl Biochem; 2020 Jan; 67(1):30-40. PubMed ID: 31538673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic manipulation of microalgae for the production of bioproducts.
    Vazquez-Villegas P; Torres-Acosta MA; Garcia-Echauri SA; Aguilar-Yanez JM; Rito-Palomares M; Ruiz-Ruiz F
    Front Biosci (Elite Ed); 2018 Jan; 10(2):254-275. PubMed ID: 28930617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapies for neurodegenerative diseases: current status and potential of plant-made biopharmaceuticals.
    Arevalo-Villalobos JI; Rosales-Mendoza S; Zarazua S
    Expert Rev Vaccines; 2017 Feb; 16(2):151-159. PubMed ID: 27579524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic plants as factories for biopharmaceuticals.
    Giddings G; Allison G; Brooks D; Carter A
    Nat Biotechnol; 2000 Nov; 18(11):1151-5. PubMed ID: 11062432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green Therapeutic Biocapsules: Using Plant Cells to Orally Deliver Biopharmaceuticals.
    Rosales-Mendoza S; Nieto-Gómez R
    Trends Biotechnol; 2018 Oct; 36(10):1054-1067. PubMed ID: 29980327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plants as bioreactors for biopharmaceuticals: regulatory considerations.
    Miele L
    Trends Biotechnol; 1997 Feb; 15(2):45-50. PubMed ID: 9081298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging trends in pulmonary delivery of biopharmaceuticals.
    Kunde SS; Ghosh R; Wairkar S
    Drug Discov Today; 2022 May; 27(5):1474-1482. PubMed ID: 35143963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outlook in the application of Chlamydomonas reinhardtii chloroplast as a platform for recombinant protein production.
    Shamriz S; Ofoghi H
    Biotechnol Genet Eng Rev; 2016; 32(1-2):92-106. PubMed ID: 28359189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulation of the microalgal chloroplast by genetic engineering for biotechnological utilization as a green biofactory.
    Kwon YM; Kim KW; Choi TY; Kim SY; Kim JYH
    World J Microbiol Biotechnol; 2018 Nov; 34(12):183. PubMed ID: 30478596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biopharmaceuticals from microorganisms: from production to purification.
    Jozala AF; Geraldes DC; Tundisi LL; Feitosa VA; Breyer CA; Cardoso SL; Mazzola PG; Oliveira-Nascimento L; Rangel-Yagui CO; Magalhães PO; Oliveira MA; Pessoa A
    Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):51-63. PubMed ID: 27838289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydomonas as a model for biofuels and bio-products production.
    Scranton MA; Ostrand JT; Fields FJ; Mayfield SP
    Plant J; 2015 May; 82(3):523-531. PubMed ID: 25641390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bio-Based Products from Microalgae Cultivated in Digestates.
    Koutra E; Economou CN; Tsafrakidou P; Kornaros M
    Trends Biotechnol; 2018 Aug; 36(8):819-833. PubMed ID: 29605178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arthrospira maxima OF15 biomass cultivation at laboratory and pilot scale from sugarcane vinasse for potential biological new peptides production.
    Montalvo GEB; Thomaz-Soccol V; Vandenberghe LPS; Carvalho JC; Faulds CB; Bertrand E; Prado MRM; Bonatto SJR; Soccol CR
    Bioresour Technol; 2019 Feb; 273():103-113. PubMed ID: 30419445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and regulation of biosimilars: current status and future challenges.
    Tsiftsoglou AS; Ruiz S; Schneider CK
    BioDrugs; 2013 Jun; 27(3):203-11. PubMed ID: 23553340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.